PyInvesting

Market research

300791.SHE Sirio Pharma Co., Ltd

SHE CNY Consumer Defensive

Latest close

16.62 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
5B
P/E ratio
41.05
Analyst target
23
Dividend yield
0.0%
Beta
0.32

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Sirio Pharma Co., Ltd. is currently in a long term downtrend where the price is trading 20.0% below its 200 day moving average.

From a valuation standpoint, the stock is 10.2% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 6.1.

Sirio Pharma Co., Ltd. 's total revenue rose by 40.6% to $538M since the same quarter in the previous year.

Its net income has increased by 100.2% to $62M since the same quarter in the previous year.

Finally, its free cash flow grew by 7084.7% to $45M since the same quarter in the previous year.

Based on the above factors, Sirio Pharma Co., Ltd. gets an overall score of 4/5.